α-Bisabolene’s distinctive aroma is highly
prized
in fragrances and cosmetics, while its antioxidant properties hold
significant pharmaceutical potential. However, the production of α-bisabolene
in Saccharomyces cerevisiae remains
an outstanding challenge due to cell growth limitations and insufficient
supply of the α-bisabolene precursor farnesyl pyrophosphate.
In this work, a new S. cerevisiae platform
strain capable of producing high levels of α-bisabolene was
presented. Carbon flux in the α-bisabolene synthesis pathway
was maximized by iterative enhancement of the mevalonate metabolic
pathway. The effects of MVA pathway intermediates on cell growth were
addressed through a two-stage fermentation controlled based on a temperature-sensitive
regulation strategy. The fermentation medium was optimized based on
metabolomics and response surface model analysis. Under the optimal
fermentation process, the titer of α-bisabolene reached 18.6
g/L during fed-batch fermentation, representing the highest titer
reported to date. These strategies open up new avenues for industrial-scale
terpene biosynthesis.